About 300 reports

The company has received approval for tbo-filgrastim (XM## filgrastim).

  • Monoclonal Antibody
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

TABLE OF CONTENTS (##/ ##) ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Supply
  • Remicade group
  • The following compounds are being studied as potential biosimilars:
  • BIOSIMILARS: MABS & BIOLOGICS PIPELINE

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Monoclonal Antibody
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

In the supportive care space, several filgrastim (Amgen' s Neupogen) biosimilars are already marketed in the ##MM.

  • Monoclonal Antibody
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Gland Surgery; ##(##): ##-## Zhang P, et al. (2016).

  • Monoclonal Antibody
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Binocrit (epoetin alfa Zarzio/ Zarxio (filgrastim) Used in therapy area of Hematology. neutropenia after chemotherapy.

  • Biopharmaceutical
  • Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

" Cost to patients is the number one issue [unmet need], number one. "

  • Monoclonal Antibody
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group

Neupogen (filgrastim) ##.

  • Monoclonal Antibody
  • Therapy
  • United States
  • Demand
  • Amgen Inc.

Neupogen (filgrastim) ##.

  • Chemotherapy
  • Monoclonal Antibody
  • North America
  • United States
  • Roche Group

IN MARCH 2015, THE US FDA APPROVED THE FIRST BIOSIMILAR, ZARXIO (FILGRASTIM BIOSIMILAR), AND IS CURRENTLY IN THE PROCESS OF FORMALIZING INDUSTRY GUIDANCE FOR BIOSIMILAR DEVELOPMENT (FDA, PRESS RELEASE, MARCH ##, 2015).

  • Monoclonal Antibody
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

NEUPOGEN (FILGRASTIM) ##.

  • Monoclonal Antibody
  • North America
  • United States
  • Demand
  • Roche Group

Neupogen (filgrastim) ##.

  • Monoclonal Antibody
  • North America
  • United States
  • Biocon Limited
  • Roche Group

Neupogen (filgrastim) ##.

  • Leukemia
  • Monoclonal Antibody
  • United States
  • Gilead Sciences, Inc.
  • Roche Group

Neupogen (filgrastim) ##.

  • Monoclonal Antibody
  • United States
  • Demand
  • Genmab group
  • Janssen Biotech, Inc.
  • TOP SELLING BIOLOGICS: ESTIMATED PATENT EXPIRY
  • BEST SELLING BIOLOGICS: REVENUES

FILGRASTIM ##. ##. ##.

  • Monoclonal Antibody
  • North America
  • United States
  • Market Size
  • Sandoz Inc.

PLoS One; ##(##): epub ACR (2013).

  • Monoclonal Antibody
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG

Neupogen (filgrastim) ##.

  • Monoclonal Antibody
  • North America
  • United States
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • 8.2 ALL PIPELINE DRUGS BY PHASE OF DEVELOPMENT

PLoS One; ##: ##-## Siddiqui M and Perry CM (2012).

  • Monoclonal Antibody
  • World
  • Market Size
  • Celgene Corporation
  • Merck & Co., Inc.

MARKET ##.

  • Monoclonal Antibody
  • Vaccine
  • APAC
  • World
  • Market Size

Skin Therapy Letter; ##(##): ##-##.

  • Monoclonal Antibody
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Monoclonal Antibody
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Monoclonal Antibody
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Monoclonal Antibody
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Amgen Inc. ## ## ## ## ## ## ## ## AbbVie Inc. ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2015 2015 trials are taken as of Augu

  • Monoclonal Antibody
  • World
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • PROVIDES AN ASSESSMENT OF CELGENE'S MULTIPLE MYELOMA PORTFOLIO.

Transplantation; ##(##): ##-##.

  • Monoclonal Antibody
  • Market Size
  • Celgene Corporation
  • Janssen Biotech, Inc.
  • Novartis AG

## Japan < ## < ## < ## < ## < ## TABLE ##: NERATINIB SALES, BY COUNTRY ($M), 2013-## 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 France Germany Italy Spain UK Total Note: totals may not sum due to rounding. ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Monoclonal Antibody
  • European Union
  • United States
  • GlaxoSmithKline plc
  • Roche Group

FILGRASTIM AS AN ALTERNATIVE TO DONOR LEUKOCYTE INFUSION FOR RELAPSE AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION.

  • Monoclonal Antibody
  • Athersys, Inc.
  • Fresenius Group
  • GlobalData's company
  • Soligenix, Inc.
  • PROVIDES AN ASSESSMENT OF CELGENE'S MULTIPLE MYELOMA PORTFOLIO.

Transplantation; ##(##): ##-##.

  • Monoclonal Antibody
  • AbbVie Inc.
  • Celgene Corporation
  • Janssen Biotech, Inc.
  • Novartis AG
  • BIOCON
  • Marketing Authorization Holder

The global biosimilars market projected to grow at a CAGR of 31.7% during the forecast period. The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR of 31.7%. Factors driving the growth of this market include increasing demand for biosimilar drugs due to their cost-effectiveness,...

  • Monoclonal Antibody
  • North America
  • United States
  • Market Size
  • Sandoz Inc.
  • Biocon Limited - Early Stage Pipeline Products
  • Biocon Limited - Pipeline by Indication, 2016

Biocon Limited - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Biocon Limited - Product Pipeline Review - 2016’, provides an overview of the Biocon Limited’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Biocon...

  • Insulin
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Biocon Limited